Advertisement

Topics

FDA Approval of Continuous Glucose Monitoring Without Confirmation of Readings

20:00 EDT 13 Sep 2017 | JAMA

This Viewpoint discusses the potential risks of the US Food and Drug Administration’s 2016 approval of the Dexcom G5 Mobile continuous glucose monitor for making diabetes treatment decisions without confirmation of the device’s readings with fingerstick or laboratory testing.

Original Article: FDA Approval of Continuous Glucose Monitoring Without Confirmation of Readings

NEXT ARTICLE

More From BioPortfolio on "FDA Approval of Continuous Glucose Monitoring Without Confirmation of Readings"

Quick Search
Advertisement